Morgan Stanley
NVNO

Morgan Stanley’s enVVeno Medical NVNO Stock Holding History

Morgan Stanley’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$632 Sell
59
-17
-22% -$183 ﹤0.01% 7596
2026
Q1 		$770 Sell
76
-6
-7% -$66 ﹤0.01% 7499
2025
Q4 		$922 Sell
82
-24
-23% -$466 ﹤0.01% 7387
2025
Q3 		$3.37K Sell
106
-2,046
-95% -$209K ﹤0.01% 7186
2025
Q2 		$301K Buy
2,152
+267
+14% +$31.6K ﹤0.01% 5688
2025
Q1 		$173K Sell
1,885
-1,742
-48% -$194K ﹤0.01% 5791
2024
Q4 		$383K Sell
3,627
-205
-5% -$22.9K ﹤0.01% 5532
2024
Q3 		$451K Buy
3,832
+1,121
+41% +$206K ﹤0.01% 5452
2024
Q2 		$498K Sell
2,711
-76
-3% -$13.3K ﹤0.01% 5294
2024
Q1 		$531K Buy
2,787
+1,057
+61% +$190K ﹤0.01% 5284
2023
Q4 		$311K Buy
1,730
+492
+40% +$78.3K ﹤0.01% 5531
2023
Q3 		$233K Buy
1,238
+181
+17% +$30.2K ﹤0.01% 5511
2023
Q2 		$114K Buy
1,057
+231
+28% +$30K ﹤0.01% 5891
2023
Q1 		$135K Sell
826
-43
-5% -$8.04K ﹤0.01% 5885
2022
Q4 		$155K Sell
869
-53
-6% -$10.8K ﹤0.01% 5772
2022
Q3 		$203K Buy
922
+114
+14% +$24.3K ﹤0.01% 5721
2022
Q2 		$107K Sell
808
-219
-21% -$34K ﹤0.01% 6235
2022
Q1 		$230K Sell
1,027
-594
-37% -$115K ﹤0.01% 5844
2021
Q4 		$374K Sell
1,621
-3,280
-67% -$924K ﹤0.01% 5719
2021
Q3 		$1.78M Buy
+4,901
New +$1.27M ﹤0.01% 4661
2019
Q1 		– Hold
0
– – – 6667
2018
Q4 		– Hold
0
– – – 6679

Other funds holding NVNO

KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley's NVNO Position: Q2 2026 in Review

Morgan Stanley reduced its enVVeno Medical (NVNO) stake by 22% in Q2 2026, selling an estimated $183 and leaving 59 shares worth $632. The position accounts for ﹤0.01% of the portfolio, ranked #7596.

Morgan Stanley first reported a position in NVNO in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.78M in Q3 2021. 17 funds tracked by Wall St. Rank hold NVNO as of Q2 2026.

  • Morgan Stanley held 59 shares of enVVeno Medical worth $632 as of Q2 2026.
  • Morgan Stanley sold 17 enVVeno Medical shares in Q2 2026, an estimated $183.
  • enVVeno Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7596 holding.
  • Morgan Stanley first reported a position in enVVeno Medical in Q3 2021 and has held it in 20 quarters since.
  • Morgan Stanley's enVVeno Medical position peaked at $1.78M in Q3 2021.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.